Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Announced positive ini ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback